Detalhe da pesquisa
1.
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.
Lancet Oncol
; 23(1): 149-160, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902335
2.
Standardizing Pathologic Evaluation of Breast Carcinoma After Neoadjuvant Chemotherapy.
Arch Pathol Lab Med
; 147(5): 591-603, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35976643
3.
Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial.
JAMA Oncol
; 7(11): 1654-1663, 2021 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34529000